glp 1 agonists and inflammation The Impact of GLP-1 Receptor on Ocular Disease GLP-1-based therapies, including GLP-1, GLP-1R
Description
The anti-inflammatory and immunological properties of SGLT-2 inhibitors

Migraine headache prophylaxis in adolescents

GLP-1 medications are considered long-term, chronic-disease therapies for both diabetes and obesity

BMC Cancer (2018) 18(1):657

doi: 10.3389/fimmu.2019.01223

has served on scientific advisory panels and/or speaker's bureaus and served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Fractyl, Gubra, Merck Sharp & Dohme, Novo Nordisk, Sanofi and Zealand Pharma
